Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667599 · ClinicalTrials.gov registry record · NA
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
A NA study of Well-being of Caregivers (Caregiver Strain Index), sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03667599: Recruiting NA study of Well-being of Caregivers (Caregiver Strain Index), sponsored by Duke University.
NCT03667599 is a NA study of Well-being of Caregivers (Caregiver Strain Index) that is actively recruiting participants, run by Duke University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667599, a NA study of Well-being of Caregivers (Caregiver Strain Index), is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
Primary Outcome
To compare the quality of life (Caregiver Strain Index) in caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
Conditions Studied
Interventions
- OTHER home care
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What NCT03667599 shows while recruiting
NCT03667599 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Well-being of Caregivers (Caregiver Strain Index) appearing as the primary indexed condition, and to 1 intervention - of which home care is the first listed.
NCT03667599 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03667599 about?
NCT03667599 is a clinical study titled "A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation". This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
What is the current status of trial NCT03667599?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-09-28. Estimated completion is 2027-01-30.
What conditions does trial NCT03667599 study?
This clinical trial studies the following conditions: Well-being of Caregivers (Caregiver Strain Index).
What interventions are being tested in trial NCT03667599?
The interventions under investigation include: home care (OTHER).
Who is sponsoring clinical trial NCT03667599?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03667599 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03667599's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI